News
FDA chief pushes back on senators’ criticism, says Covid booster trials should take ‘roughly a year’
The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of ...
As the Trump administration’s FDA moves to limit approval for COVID-19 booster shots, millions of Americans under 65 may find ...
SWEATING THE MAHA REPORT — A report expected today from Robert F. Kennedy Jr. on childhood chronic diseases could spark ...
Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...
Private equity ownership of psychiatric hospitals grew rapidly from 2013 to 2021, but the quality of care did not diminish ...
The move means Harvard may no longer enroll foreign students, and existing foreign students must transfer or risk losing their legal status, DHS said, adding that Harvard had created an "unsafe campus ...
FDA Commissioner Dr. Marty Makary and vaccine chief Dr. Vinay Prasad set stricter approval standards for booster shots ...
In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...
Wellbeing Whisper on MSN1d
Why Most Americans Won't Need Covid Boosters Anymore and What It Means for YouWe want to know more about what these products are doing,” said Dr. Vinay Prasad during a recent FDA livestreamed ...
US regulators will no longer approve Covid booster shots for healthy adults and children without new studies, adding a costly ...
The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback